INOVIO announced that the Food and Drug Administration granted accelerated approval to VOCERYQ™ for adults with recurrent ...
Strategic Combination Brings Highly Innovative Late-Stage D-Fi Franchise Targeting Rare Diseases, with Orphan Drug-Designated ...
AMS is a European full-service CRO headquartered in Mannheim, Germany, with additional offices within Germany, Spain and in ...
Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that ...
To verify the clinical benefit of VOCERYQ, a confirmatory study is expected to be conducted. The FDA requires INOVIO to ...
SignalSpace brings product and trial data into one connected environment, where AI agents dramatically improve data access ...
The Philadelphia Convention and Visitors Bureau (PHLCVB) is thrilled to welcome Melissa Callum as executive director of PHL ...
The Troiano Brain Tumor Center will leverage Penn-led discoveries and expertise through innovation, first-in-human clinical ...
Emvena Therapeutics is the first company launched by the fund, advancing placenta-targeted mRNA medicines for serious ...
Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision-guided biotech/life sciences company focused on advancing the clinical ...
AUDUBON, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. a leading musculoskeletal technology company, today ...
The Introduction to the Biopharmaceutical Manufacturing event hosted by BioHub Maryland, Powered by the Maryland Tech Council ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results